Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.89B |
| 2 |
Tesla
TSLA
|
+$788M |
| 3 |
Broadcom
AVGO
|
+$772M |
| 4 |
Amazon
AMZN
|
+$768M |
| 5 |
Workday
WDAY
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.5B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$898M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$565M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$441M |
| 5 |
Palo Alto Networks
PANW
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.36% |
| 2 | Consumer Discretionary | 2.24% |
| 3 | Healthcare | 1.2% |
| 4 | Financials | 1.17% |
| 5 | Communication Services | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
CALL
General Mills
GIS
$19.3B
| $19.1M | 0.01% |
292,900
-77,100
| -21% | -$4.98M |
|
1302
Lamb Weston
LW
$7.16B
| $19.1M | 0.01% |
176,290
-60,404
| -26% | -$5.82M |
|
1303
Maplebear
CART
$10.6B
| $19.1M | 0.01% |
811,790
+774,757
| +2,092% | +$19.5M |
|
1304
CALL
Cheniere Energy
LNG
$54.9B
| $19.1M | 0.01% |
111,600
-86,000
| -44% | -$14.8M |
|
1305
PUT
KB Home
KBH
$3.49B
| $19M | ﹤0.01% |
304,100
-34,100
| -10% | -$1.75M |
|
1306
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
| $18.9M | ﹤0.01% |
196,100
+143,000
| +269% | +$12.7M |
|
1307
VanEck High Yield Muni ETF
HYD
$4.44B
| $18.9M | ﹤0.01% |
366,059
+243,680
| +199% | +$12.1M |
|
1308
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.13B
| $18.9M | ﹤0.01% |
401,968
-556,064
| -58% | -$24.9M |
|
1309
BlackRock Total Return ETF
BRTR
$737M
| $18.9M | ﹤0.01% |
+367,417
| New | +$18.9M |
|
1310
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.64B
| $18.9M | ﹤0.01% |
687,809
+318,894
| +86% | +$8.29M |
|
1311
PUT
XPeng
XPEV
$11.2B
| $18.9M | ﹤0.01% |
1,292,100
+577,800
| +81% | +$9.18M |
|
1312
Alexandria Real Estate Equities
ARE
$8.34B
| $18.8M | ﹤0.01% |
148,613
-30,410
| -17% | -$3.27M |
|
|
IMGN
1313
DELISTED
Immunogen Inc
IMGN
| $18.8M | ﹤0.01% |
634,353
-283,411
| -31% | -$5.64M |
|
1314
iShares MSCI Israel ETF
EIS
$888M
| $18.8M | ﹤0.01% |
323,078
+196,484
| +155% | +$10.3M |
|
1315
CALL
Sherwin-Williams
SHW
$88.2B
| $18.7M | ﹤0.01% |
60,100
-38,000
| -39% | -$10.2M |
|
|
IPFF
1316
CALL
DELISTED
iShares International Preferred Stock ETF
IPFF
| $18.7M | ﹤0.01% |
368,900
-616,700
| -63% | -$31.3M |
|
1317
PUT
Alnylam Pharmaceuticals
ALNY
$28.9B
| $18.7M | ﹤0.01% |
97,900
-11,600
| -11% | -$1.98M |
|
1318
CALL
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.5B
| $18.7M | ﹤0.01% |
1,089,500
+618,600
| +131% | +$8.52M |
|
1319
UiPath
PATH
$7.25B
| $18.7M | ﹤0.01% |
752,421
+535,793
| +247% | +$10.5M |
|
1320
Advance Auto Parts
AAP
$3.49B
| $18.7M | ﹤0.01% |
305,889
+78,574
| +35% | +$4.3M |
|
|
1321
Sherwin-Williams
SHW
$88.2B
| $18.7M | ﹤0.01% |
59,827
+11,456
| +24% | +$3.08M |
|
1322
KE Holdings
BEKE
$18.7B
| $18.6M | ﹤0.01% |
1,150,191
+511,011
| +80% | +$7.9M |
|
1323
PUT
NIO
NIO
$11.5B
| $18.6M | ﹤0.01% |
2,055,600
-503,300
| -20% | -$3.99M |
|
1324
PUT
CME Group
CME
$95B
| $18.6M | ﹤0.01% |
88,500
+57,600
| +186% | +$12.3M |
|
|
1325
Alnylam Pharmaceuticals
ALNY
$28.9B
| $18.6M | ﹤0.01% |
97,363
+42,327
| +77% | +$7.21M |
|
Similar funds
Jane Street's Q4 2023 Portfolio in Review
As of Q4 2023, Jane Street held 10,187 positions worth $384B, up 24% from $309B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jane Street deployed $33.7B of net new capital in Q4 2023, opening 1,659 new positions and adding to 4,053 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 2.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.5B trimmed.
- Jane Street's largest Q4 2023 buy was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
- Jane Street added most to Microsoft in Q4 2023, an estimated $1.89B increase.
- Jane Street's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.5B.
- Jane Street fully exited JPMorgan USD Emerging Markets Sovereign Bond ETF in Q4 2023, selling an estimated $121M.
- Jane Street's ten largest holdings make up 38% of its $384B portfolio in Q4 2023.
- Jane Street opened 1,659 new positions and closed 1,080 in Q4 2023.
- Jane Street's portfolio value rose 24% quarter-over-quarter to $384B.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.